###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Rrp1b, a New Candidate Susceptibility Gene for Breast Cancer Progression and Metastasis
###end article-title 0
###begin p 1
###xml 39 75 39 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ribosomal RNA processing 1 homolog B</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 856 861 856 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1063 1068 1063 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1197 1202 1197 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1333 1338 1333 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 143 148 <span type="species:ncbi:4932">yeast</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
###xml 1108 1113 <span type="species:ncbi:9606">human</span>
A novel candidate metastasis modifier, ribosomal RNA processing 1 homolog B (Rrp1b), was identified through two independent approaches. First, yeast two-hybrid, immunoprecipitation, and functional assays demonstrated a physical and functional interaction between Rrp1b and the previous identified metastasis modifier Sipa1. In parallel, using mouse and human metastasis gene expression data it was observed that extracellular matrix (ECM) genes are common components of metastasis predictive signatures, suggesting that ECM genes are either important markers or causal factors in metastasis. To investigate the relationship between ECM genes and poor prognosis in breast cancer, expression quantitative trait locus analysis of polyoma middle-T transgene-induced mammary tumor was performed. ECM gene expression was found to be consistently associated with Rrp1b expression. In vitro expression of Rrp1b significantly altered ECM gene expression, tumor growth, and dissemination in metastasis assays. Furthermore, a gene signature induced by ectopic expression of Rrp1b in tumor cells predicted survival in a human breast cancer gene expression dataset. Finally, constitutional polymorphism within RRP1B was found to be significantly associated with tumor progression in two independent breast cancer cohorts. These data suggest that RRP1B may be a novel susceptibility gene for breast cancer progression and metastasis.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1004 1009 1004 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1106 1111 1106 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1230 1235 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1356 1361 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 871 876 <span type="species:ncbi:9606">human</span>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
###xml 1299 1305 <span type="species:ncbi:9606">humans</span>
Metastasis, which is defined as the spread of malignant tumor cells from their original site to other parts of the body, accounts for the vast majority of solid cancer-related mortality. Our laboratory has previously shown that host germline-encoded variation modifies primary tumor metastatic capacity. Here, we detail how germline-encoded Rrp1b variation likely modulates metastasis. In mice, constitutional Rrp1b variation correlates with ECM gene expression, which are genes commonly differentially regulated in metastasis prone tumors. Furthermore, we demonstrate that Rrp1b expression levels are modulated by germline variation in mice with differing metastatic propensities, and that variation of Rrp1b expression in a highly metastatic mouse mammary tumor cell line modifies progression. Differential RRP1B functionality also appears to play an important role in human breast cancer progression. Specifically, we demonstrate that a microarray gene expression signature indicative of differential RRP1B expression predicts breast cancer-specific survival. Furthermore, we show that germline-encoded RRP1B variation is associated with markers of outcome in two breast cancer populations. In summary, these data suggest that Rrp1b may be a germline-encoded metastasis modifier in both mice and humans, which leads to the possibility that knowledge of RRP1B functionality and variation in breast cancer might facilitate improved assessment of prognosis.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b001">1</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b002">2</xref>
###xml 144 149 <span type="species:ncbi:9606">women</span>
###xml 496 501 <span type="species:ncbi:9606">women</span>
###xml 672 677 <span type="species:ncbi:9606">women</span>
Most cancer-related mortality is a consequence of metastasis, and the vast majority of deaths from breast cancer, the most common malignancy of women in the United States [1], are attributable to disseminated disease. Disseminated breast cancer is still considered incurable in spite of therapeutic advances [2], and a more comprehensive understanding of the biology of tumor progression is therefore necessary to facilitate development of improved treatments. This includes the ability to spare women at low risk of metastasis from needless additional therapy, while allowing earlier initiation of aggressive treatment to reduce the incidence and extent of metastasis in women with poorer prognoses.
###end p 6
###begin p 7
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b003">3</xref>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b004">4</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b005">5</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b006">6</xref>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b007">7</xref>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIPA1</italic>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b007">7</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b008">8</xref>
###xml 880 885 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 1144 1149 1144 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 480 485 <span type="species:ncbi:10090">mouse</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 1063 1068 <span type="species:ncbi:9606">human</span>
###xml 1223 1227 <span type="species:ncbi:10090">mice</span>
###xml 1232 1238 <span type="species:ncbi:9606">humans</span>
We previously demonstrated the significant influence of germline variation on tumor progression [3,4], which allowed us to identify the first known heritable mouse gene that modulates metastasis [5,6], the Rap-GTPase activating protein (GAP) Sipa1 [7]. Subsequent human studies demonstrated that SIPA1 polymorphisms are associated with metastatic cancer [7] and poor outcome in breast cancer [8], validating the utility of the highly metastatic polyoma middle-T (PyMT) transgenic mouse model to identify relevant human metastasis modifiers. The current study represents the convergence of two parallel strategies to enhance our understanding of the role of heritable factors in metastasis. Using in vitro, genetic, and epidemiologic analyses, we have identified ribosomal RNA processing 1 homolog B (Rrp1b) as a factor that physically interacts with the metastasis modifier gene, Sipa1, modulates elements of metastasis predictive gene expression signatures, suppresses tumor progression in animal models, and is associated with progression and survival in pilot human breast cancer epidemiology cohorts. This integrated approach suggests that Rrp1b is a novel tumor progression and metastasis susceptibility locus in both mice and humans.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Rrp1b Forms a Complex with Sipa1 and Inhibits Sipa1 Gap Activity
###end title 9
###begin p 10
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b007">7</xref>
###xml 289 297 289 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st001">Table S1</xref>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st002">Table S2</xref>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 164 169 <span type="species:ncbi:4932">Yeast</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
Previous mouse studies demonstrated that a polymorphism in Sipa1 in the region encoding a PDZ protein-protein interaction domain is associated with metastasis [7]. Yeast two-hybrid screening of Sipa1 was therefore performed to identify additional genes potentially involved in metastasis (Table S1). Following sequence alignment, 29 clones were found to bind to at least one of the SIPA1 baits (Table S2). One of these was RRP1B (the human homolog of Rrp1b), which was identified by a probe spanning the PDZ domain.
###end p 10
###begin p 11
###xml 398 406 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g001">Figure 1</xref>
###xml 604 612 604 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g001">Figure 1</xref>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
To confirm the interaction, HEK293 cells were cotransfected with epitope-tagged mouse Rrp1b and Sipa1. AQP2, which also interacts with the PDZ domain of Sipa1, was cotransfected with Sipa1 as a positive control. Cell extracts were then immunoprecipitated with Sipa1 antibodies and blotted with V5-antibodies (V5 was the epitope fused to Rrp1b in this experiment), revealing an Rrp1b-specific band (Figure 1A, upper panel, lane 5). Conversely, when HA-tagged Rrp1b was cotransfected with V5-tagged Sipa1, immunoprecipitation with an HA-antibody followed by western blotting yielded a Sipa1-specific band (Figure 1B, upper panel, lane 3).
###end p 11
###begin title 12
Rrp1b Forms a Complex with Sipa-1 and Inhibits its RapGAP Activity
###end title 12
###begin p 13
(A) and (B) Complex formation between Rrp1b and Sipa1, and between AQP2 and Sipa1. AQP2 or Rrp1b-V5 (A) or Rrp1b-HA (B) was expressed singly or coexpressed with Sipa1-V5 in 293 cells as indicated. In (A), anti-Sipa1 immunocomplexes were immunoblotted with anti-V5 antibodies (top western blot (WB) panel) or anti-AQP2 antibodies (next WB panel). In (B), anti-Rrp1b-HA immunocomplexes were immunoblotted with anti-Sipa1-V5 antibody (WB panel). In the two lower panels of A and B, the immunoblots show the expression in cell extracts of exogenous Rrp1b-V5, Sipa1-V5, AQP2, and Rrp1b-HA.
###end p 13
###begin p 14
(C) Inhibition of Sipa1 RapGAP Activity by AQP2 and Rrp1b. In cells expressing Epac, Sipa1-V5 was expressed with AQP2 or Rrp1b-V5 as indicated. The in vivo Rap1GTP levels were assayed by RalGDS-RBD pull-down (top panel). In the lower panels, the immunoblots show the expression of endogenous Rap1, and the exogenous proteins: Sipa1-V5, Rrp1b-V5, AQP2, and Epac-HA. The Rap1 and EpacHA immunoblots also serve as loading controls.
###end p 14
###begin p 15
###xml 251 259 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g001">Figure 1</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b007">7</xref>
As further validation, the functional consequence of the Rrp1b-Sipa1 interaction on the Rap-GTPase enzymatic activity of Sipa1 was examined. HEK293 cells were cotransfected with a Rap exchange factor, Epac, and Sipa1 in the presence of AQP2 or Rrp1b (Figure 1C). AQP2, which has been shown previously to interfere with the RapGAP activity of Sipa1 [7], was used as a positive control. In the absence of Sipa1, Epac induced an increase in Rap-GTP, regardless of whether the cells also expressed AQP2 or Rrp1b (upper panel, lanes 1-3), indicating that Rrp1b did not directly affect Rap-GTP levels. As expected, the presence of Sipa1 reduced Epac-induced Rap-GTP levels (upper panel, lane 4). This reduction was partially inhibited by AQP2 or Rrp1b (upper panel, lanes 5 and 6, respectively). Thus Rrp1b, like AQP2, inhibits the RapGAP activity of Sipa1.
###end p 15
###begin title 16
###xml 50 54 <span type="species:ncbi:10090">Mice</span>
Expression QTL Mapping in AKXD Recombinant Inbred Mice
###end title 16
###begin p 17
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b009">9</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b011">11</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b012">12</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
Examination of published reports describing primary human breast tumor expression profiles predicting metastasis or disease outcome reveals a common association with the expression levels of extracellular matrix (ECM) genes [9-11]. Similar ECM-rich metastasis-predictive signatures also exist in PyMT-induced mouse mammary tumors [12]. The consistent association of ECM gene expression levels with outcome suggests that differential ECM gene expression is either a causative factor or marker of metastatic potential.
###end p 17
###begin p 18
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-sd001">Text S1</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b014">14</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b003">3</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b015">15</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b016">16</xref>
###xml 999 1007 999 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g002">Figure 2</xref>
###xml 1012 1019 1012 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-sd001">Text S1</xref>
###xml 1170 1179 1170 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-sg001">Figure S1</xref>
###xml 1352 1353 1340 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b006">6</xref>
###xml 1397 1402 1385 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
In a set of experiments performed concurrently with our efforts to identify proteins interacting with SIPA1, the relationship between ECM gene expression and metastasis susceptibility was further characterized by investigating the inherited origins of metastasis-predictive gene signatures. Specifically, expression quantitative trait locus (eQTL) mapping of ECM gene expression was performed to identify genomic regions associated with ECM gene expression (see Text S1). To achieve this, we analyzed microarray data derived from PyMT-induced primary tumors in the AKXD RI panel recombinant inbred (RI) mice [13,14], a panel of RI mice derived from high metastatic potential AKR/J and low metastatic potential DBA/2J strains [3]. An Internet-based analytical package/repository that allows for analysis of RI microarray expression data called WebQTL [15,16] was used to map ECM eQTLs. Reproducible, statistically significant or suggestive ECM eQTLs were discovered on chromosomes 7, 17, and 18 (see Figure 2 and Text S1), implying that loci from these three regions regulate much of the metastasis-predictive ECM gene expression in AKXD tumors. The chromosome 17 locus (Figure S1) was of particular interest, as its peak linkage region (approximately29.5 Mb) colocalizes with a previously described metastasis efficiency and tumor growth kinetics QTL [6], and encompasses the physical location of Rrp1b (approximately29.9 Mb).
###end p 18
###begin title 19
###xml 29 34 <span type="species:ncbi:10090">Mouse</span>
eQTL Analysis in the AKXD RI Mouse Panel
###end title 19
###begin p 20
###xml 954 962 954 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serping1</italic>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nid1</italic>
###xml 970 976 970 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 978 984 978 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a2</italic>
###xml 986 992 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col3a1</italic>
###xml 994 998 994 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbn1</italic>
###xml 1004 1008 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
Analysis of metastasis class-predictive ECM gene component expression patterns in PyMT transgene-induced tumors in AKXD recombinant inbred mice reveals the presence of three relatively consistent eQTLs on chromosomes 7, 17, and 18. The diagram on the left shows an eQTL cluster map generated with WebQTL. The warm hues reflect an LRS for increased transcription in mice with the DBA/2J genotype at any given locus, and the cool hues represent LRS for elevated transcription in mice with the AKR/J allele. The strongest degree of linkage is observed with the chromosome 17 eQTL, as illustrated in the three QTL scans on the right. In total, nine of the 16 metastasis-predictive probes displayed a LRS that was at least suggestive of linkage (denoted by the warm hues on the heat map to the left) suggesting that their expression is controlled in some respect by the chromosome 17 locus. These probes are located within the metastasis-predictive ECM genes Serping1, Nid1, Col1a1, Col1a2, Col3a1, Fbn1, and Mmp2. Rrp1b lies in very close physical proximity to the peak LRS within the chromosome 17 locus and displays a high degree of correlation of expression with a number of class-predictive ECM genes.
###end p 20
###begin p 21
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b016">16</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b017">17</xref>
###xml 728 729 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 836 844 824 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st003">Table S3</xref>
###xml 847 852 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 951 959 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st003">Table S3</xref>
###xml 1271 1276 1259 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
Based on the current prevailing hypothesis that most modifiers are likely to result from modest variations in gene expression levels or mRNA stability [16,17], identification of potential candidates for the chromosome 17 ECM modifiers was performed by correlation analysis. Genes were correlated with ECM gene expression on a genome-wide scale using the Trait Correlation function of WebQTL. The results were subsequently filtered to examine only those genes that were present under each of the ECM eQTL peaks. Thirty genes located within a genomic region spanning the peak likelihood ratio statistic (LRS) score (physical locations on chromosome 17 approximately 18-40 Mb) displayed both a high degree of correlation and a low p value with regard to expression of two or more of the nine probes within metastasis-predictive ECM genes (Table S3). Rrp1b was one of those genes that displayed high levels of expression correlation with ECM gene probes (Table S3). This gene was selected for further analysis for the following reasons: (a) its physical proximity to the peak eQTL linkage; (b) its apparent correlation with expression of various metastasis-predictive ECM genes; and (c) that it had also been identified as interacting with the metastasis efficiency modifier Sipa1. The effects of other genes within the eQTL linkage region upon metastasis remain under investigation, but their potential role in the modulation of metastasis efficiency (if any) is beyond the scope of the current study.
###end p 21
###begin title 22
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Ectopic Expression of Rrp1b Modulates ECM Gene Expression
###end title 22
###begin p 23
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b018">18</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b019">19</xref>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 486 487 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 509 514 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 533 538 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 572 573 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 703 709 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 711 717 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col3a1</italic>
###xml 719 725 715 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col6a2</italic>
###xml 727 732 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbln2</italic>
###xml 734 738 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbn1</italic>
###xml 740 745 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mfap5</italic>
###xml 747 755 743 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serpinf1</italic>
###xml 761 769 757 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serping1</italic>
###xml 775 782 771 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t001">Table 1</xref>
###xml 833 838 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1007 1012 1003 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1020 1027 1016 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t001">Table 1</xref>
###xml 1046 1051 1042 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1418 1423 1414 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
To confirm the role of Rrp1b in the regulation of ECM expression, cell lines stably over-expressing Rrp1b were generated in the highly metastatic mouse mammary tumor cell lines Mvt-1, which is derived from FVB/NJ mice [18] and 4T1, which is derived from BALB mice [19]. Multiple individual clones were generated by clonal dilution, and ectopic expression of Rrp1b confirmed by quantitative real-time PCR (qPCR) (ratio of Rrp1b expression in Mvt-1/Rrp1b versus controls = 3.28 +/- 0.41; p = 0.001 and ratio of Rrp1b expression in 4T1/Rrp1b versus controls = 4.55 +/- 0.95; p = 0.015). Metastasis-predictive ECM gene expression was then quantified, and expression of eight of the 12 quantified ECM genes (Col1a1, Col3a1, Col6a2, Fbln2, Fbn1, Mfap5, Serpinf1, and Serping1; see Table 1) was significantly changed in response to ectopic Rrp1b expression in the Mvt-1 cell line. Expression analysis of five of six significantly dysregulated genes in the 4T1 cell lines changed in the same direction as the Mvt-1/Rrp1b cells (Table 1), suggesting that Rrp1b modulation of ECM genes was not a unique characteristic of the Mvt-1 epithelial cell line. To confirm that these results were not an artifact of the Mvt-1 and 4T1 tumor cell lines, the experiment was repeated in NIH-3T3 fibroblasts. Of the six metastasis-predictive ECM genes dysregulated in all three cell lines, four showed the same profile in response to ectopic Rrp1b expression. The remaining discrepancies are likely due to experimental variability, differently regulated genes in epithelial (i.e., Mvt-1, 4T1) and mesenchymal cells (i.e., NIH-3T3), or the effects of the differing genetic backgrounds of the three cell lines.
###end p 23
###begin p 24
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 53 58 <span type="species:ncbi:10090">Mouse</span>
###xml 111 116 <span type="species:ncbi:10090">Mouse</span>
Ectopic Expression of Rrp1b in the Highly Metastatic Mouse Mammary Tumor Cell Lines Mvt-1 and 4T1, and NIH-3T3 Mouse Fibroblasts Modulates Expression of Various Metastasis Predictive ECM Genes
###end p 24
###begin p 25
###xml 167 176 167 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-sg002">Figure S2</xref>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Growth curves were plotted for the Mvt-1 cell lines to confirm that the observed changes in gene expression in did not result from differential cellular growth rates (Figure S2). The growth of Rrp1b-transfected cell lines did not significantly differ from the growth rate of the control cell lines implying that the observed differences in metastasis-predictive gene expression are intrinsically related to the effects of Rrp1b rather than secondary to reduced growth kinetics. Similarly, no differences in growth rates were observed with the 4T1 and NIH-3T3 cells ectopically expressing Rrp1b compared to control cell lines (unpublished data).
###end p 25
###begin title 26
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Tumor Growth and Metastatic Potential Are Reduced by Ectopic Expression of Rrp1b
###end title 26
###begin p 27
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 119 137 119 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 240 245 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 288 306 285 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 869 874 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 943 948 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 994 1012 984 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 1020 1021 1007 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1032 1040 1019 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g003">Figure 3</xref>
###xml 1112 1117 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1158 1176 1141 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 1184 1185 1164 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1196 1204 1176 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g003">Figure 3</xref>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
Spontaneous metastasis assays were performed by subcutaneously implanting equal amounts of either Mvt-1/Rrp1b or Mvt-1/beta-galactosidase clones into virgin FVB/NJ female mice. Specifically, the in vivo growth characteristics of four Mvt-1/Rrp1b clones were compared to that of one Mvt-1/beta-galactosidase cell line. Since previous experiments have demonstrated that the in vitro and in vivo growth characteristics of the multiple independent isolates of the control cell line are virtually identical to those of the wild-type cell line, only one such cell line was used to minimize the number of animals in accordance with National Cancer Institute Animal Care and Use guidelines. Tumor weight and lung surface metastasis count were quantified following a four-week incubation period. Both tumor growth and lung surface metastasis were significantly reduced in Mvt-1/Rrp1b clonal isolates. Average tumor weight was 240 mg +/- 200 mg for the Rrp1b clones compared to 600 mg +/- 270 mg for the beta-galactosidase clone (p < 0.001) (Figure 3A), and average lung surface metastasis count being 5.7 +/- 6.0 for the Rrp1b clones compared to 12.6 +/- 8.4 for the beta-galactosidase clone (p = 0.010) (Figure 3B).
###end p 27
###begin title 28
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Ectopic Expression of Rrp1b Reduces (A) Tumor Growth and (B) Metastasis Burden in the Highly Metastatic Mvt-1 Cell Line
###end title 28
###begin p 29
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 101 119 101 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 350 355 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 492 510 489 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
Mvt-1 cell lines were stably transfected with a mammalian expression vector encoding either Rrp1b or beta-galactosidase. Following isolation of individual clones by serial dilution and confirmation of ectopic gene expression, clonal isolates were subcutaneously implanted in FVB/NJ mice. Those mice implanted with Mvt-1 clones ectopically expressing Rrp1b developed smaller primary tumors and fewer pulmonary metastases compared to mice implanted with a clonal isolate ectopically expressing beta-galactosidase.
###end p 29
###begin title 30
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Rrp1b Promoter Is More Active in Low-Metastatic DBA/2J Than in High-Metastatic AKR/J
###end title 30
###begin p 31
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 615 623 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st004">Table S4</xref>
Genomic sequencing of Rrp1b was performed from high (AKR/J, FVB/NJ) and low (I/lnJ, DBA/2J, and NZB/B1NJ) metastatic inbred strains to identify polymorphisms that might account for the differential ECM gene expression. Of particular interest were polymorphisms identified in the AKR/J and DBA/2J strains, since these are the progenitors of the AKXD RI panel. In addition to multiple intronic polymorphisms, the AKR/J Rrp1b proximal promoter contained two adenosine insertion polymorphisms located 1,132 bp and 1,540 bp upstream of the transcription initiation site. Rrp1b polymorphisms in all strains are listed in Table S4.
###end p 31
###begin p 32
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 382 391 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-sg003">Figure S3</xref>
###xml 393 401 393 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st005">Table S5</xref>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
To examine the functional consequences of the AKR/J promoter polymorphisms, a region 1.67 kb upstream of the transcription initiation site of Rrp1b from AKR/J and DBA/2J was cloned into pBlue-TOPO (Invitrogen). Following normalization for transfection efficiency it was found that the AKR/J proximal promoter activity was reduced 30% relative to its DBA/2J counterpart (p < 0.001) (Figure S3; Table S5) implying a subtle functional difference in Rrp1b functionality between the high and low metastatic genotypes.
###end p 32
###begin p 33
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 757 762 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 853 854 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 865 873 849 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st006">Table S6</xref>
###xml 1038 1043 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
Given the outcome of the promoter activity experiments, we would expect to observe differential expression of Rrp1b in tissue derived from the AKXD ancestral AKR/J and DBA/2J strains. To test this hypothesis, we quantified expression of Rrp1b in normal mammary tissue from AKR/J or DBA/2J genotype mice. Following total RNA extraction from the mammary tissue from three individual AKR/J mice and three DBA/2J mice, reverse-transcription PCR (RT-PCR) was used to synthesize cDNA, and Rrp1b expression determined using qPCR. Rrp1b expression was found to be approximately30% less in normal mammary tissue derived from high metastatic potential AKR/J mice compared to mammary tissue from the low metastatic potential DBA/2J genotype (AKR/J normalized relative Rrp1b quantity = 1.21 +/- 0.20, DBA/2J relative expression = 1.70 +/- 0.30; Mann Whitney U-test p = 0.0495; Table S6). Combined, the in vitro and in vivo data imply that germline polymorphism, in the form of proximal promoter polymorphism, is causing differential functionality of Rrp1b in genetic backgrounds of differential metastatic capacity.
###end p 33
###begin title 34
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 91 96 <span type="species:ncbi:9606">Human</span>
A Gene Expression Signature Indicative of Ectopic Expression of Rrp1b Predicts Survival in Human Breast Cancer
###end title 34
###begin p 35
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b020">20</xref>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 386 404 386 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 425 430 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 596 597 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 911 920 908 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st007">Tables S7</xref>
###xml 923 925 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st008">S8</xref>
If RRP1B is at least partially responsible for the presence of the ECM components of metastasis predictive gene signatures, it would suggest that a signature of RRP1B activation or expression [20] might also be predictive of breast cancer survival. To test this hypothesis, Affymetrix microarrays were used to compare gene expression in four Mvt-1/Rrp1b clonal isolates and three Mvt-1/beta-galactosidase clonal isolates. An Rrp1b expression signature was identified using the Class Comparison tool of BRB ArrayTools was performed, using a two-sample t-test with random variance univariate test. p-Values for significance were computed based on 10,000 random permutations, at a nominal significance level of each univariate test of 0.0001. A total of 1,739 probe sets representing 1,346 genes passed these conditions. Significantly upregulated and downregulated probes according to these criteria are listed in Tables S7 & S8, respectively.
###end p 35
###begin p 36
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b010">10</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b010">10</xref>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 978 986 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g004">Figure 4</xref>
###xml 1092 1100 1092 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st009">Table S9</xref>
###xml 1164 1169 1164 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1290 1292 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b010">10</xref>
###xml 1295 1303 1295 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g004">Figure 4</xref>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 205 210 <span type="species:ncbi:10090">mouse</span>
A human RRP1B gene expression signature was generated by mapping the differentially regulated genes from mouse array data to human Rosetta probe set annotations [10]. One hundred ninety six genes from the mouse data could be mapped to the available Rosetta Hu25K chip annotations. The 295 samples of the Rosetta data set [10] were clustered into one of two groups representing high and low levels of RRP1B activation in primary tumor samples in an unsupervised manner based on the 196 significantly differentially expressed RRP1B signature genes on the Hu25K chip. Kaplan-Meier survival analysis was performed to investigate whether there was a survival difference between groups. A significant survival difference was observed implying that the level of activation of RRP1B or RRP1B-associated pathways within a tumor, presumably because of either somatic mutation or germline polymorphism, may be an important determinant of the overall likelihood of relapse and/or survival (Figure 4A). Further analysis indicated that survival was associated primarily because of the effects of 33 genes (Table S9). The degree of survival difference represented by the 33-gene RRP1B-induced gene expression signature was similar to the original 70-gene signature described by van't Veer and colleagues [10] (Figure 4B).
###end p 36
###begin title 37
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
The RRP1B Microarray Expression Signature Predicts Survival into Good and Poor Outcome Groups Based on Tumor Gene Expression
###end title 37
###begin p 38
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b010">10</xref>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 924 929 924 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1007 1012 1007 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1234 1239 1234 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1430 1435 1430 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1595 1600 1595 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 656 664 <span type="species:ncbi:9606">patients</span>
###xml 846 854 <span type="species:ncbi:9606">patients</span>
###xml 1042 1050 <span type="species:ncbi:9606">patients</span>
###xml 1282 1290 <span type="species:ncbi:9606">patients</span>
###xml 1344 1352 <span type="species:ncbi:9606">patients</span>
###xml 1545 1553 <span type="species:ncbi:9606">patients</span>
(A) The RRP1B signature was highly predictive of overall survival in the Dutch Rosetta dataset, with the cumulative proportion survival being estimated to be 72% versus 34% for the good and poor prognosis RRP1B signatures, respectively (RRP1B signature HR = 3.28, 95% CI = 2.11-5.11). (B) Indeed, it appears that the RRP1B signature possesses a similar ability to predict survival in this dataset than the 70-gene signature described by van't Veer et al. [10]. Specifically, the survival for the good and poor prognosis 70-gene signatures were estimated to be 73% versus 47%, respectively (70 gene signature HR = 4.49, 95% CI = 2.65-7.61). (C) To stratify patients more adequately based upon their disease characteristics, RRP1B signature gene expression was examined with respect to tumor LN and ER status. Overall survival in the Dutch Rosetta patients with negative LNs was 79% versus 30% for the good and poor prognosis RRP1B signatures, respectively (HR = 4.34, 95% CI = 2.36-7.99). (D) Similarly, the RRP1B signature could sub-stratify patients with positive LNs into good and poor prognosis groups, with survivals being 65% versus 37%, respectively (HR = 2.38, 95% CI = 1.22-4.62). (E) A similar stratification effect by tumor RRP1B signature gene expression was observed in patients with ER positive tumors, with an overall survival in patients with ER positive tumors being 72% versus 50% for the good and poor prognosis RRP1B signatures, respectively (HR = 2.36, 95% CI = 1.17-4.77). (F) However, it did not prove possible to stratify patients with ER negative tumors based upon their RRP1B expression signature. This likely reflects the lack of individuals with this disease subtype in this cohort.
###end p 38
###begin p 39
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g004">Figure 4</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g004">4</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g004">4</xref>
###xml 508 516 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g004">Figure 4</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
###xml 430 438 <span type="species:ncbi:9606">Patients</span>
Patient samples were stratified by estrogen receptor (ER) and lymph node (LN) status, two clinically relevant prognostic markers, to determine whether the RRP1B signature might provide additional clinical stratification. Expression of the RRP1B signature in bulk primary tumor tissue predicted outcome in patients that were both LN negative and LN positive and patients with ER positive tumors (Figure 4C, 4D & 4E, respectively). Patients with ER negative tumors did not show a significant survival benefit (Figure 4F). However, this may be due to the limited sample size and needs to be clarified with additional studies.
###end p 39
###begin title 40
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 18 23 <span type="species:ncbi:9606">Human</span>
A Polymorphism in Human RRP1B Is Associated with Improved Outcome: Orange County Cohort
###end title 40
###begin p 41
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 256 265 254 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st010">Table S10</xref>
###xml 335 336 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 460 461 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 471 478 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t002">Table 2</xref>
###xml 1051 1052 1049 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1185 1186 1183 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1409 1410 1407 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1625 1626 1621 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1886 1893 1882 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t002">Table 2</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
###xml 861 869 <span type="species:ncbi:9606">patients</span>
###xml 1011 1019 <span type="species:ncbi:9606">patients</span>
###xml 1259 1267 <span type="species:ncbi:9606">patients</span>
###xml 1481 1489 <span type="species:ncbi:9606">patients</span>
###xml 1521 1529 <span type="species:ncbi:9606">patients</span>
###xml 1541 1549 <span type="species:ncbi:9606">patients</span>
To validate a possible role of RRP1B in human cancer, a case-only pilot breast cancer association study was performed to assess the role of a nonsynonymous SNP within the human homolog of Rrp1b (dbSNP ID: rs9306160; 1421G-->A, Pro436Leu) in human disease (Table S10). The variant A allele frequency in this Caucasian cohort was 0.362 (n = 269). Univariate analysis revealed a significant difference with respect to disease stage (localized versus nonlocalized p = 0.006; Table 2). Of the 130 patients with localized disease at diagnosis, 85 (65%) were carriers of the variant allele compared with 74 of 139 (53%) of those with advanced regional or metastatic disease. Significant associations were also observed with tumor ER and progesterone receptor (PR) status, the presence of LN disease, and primary tumor grade. The variant allele was more frequent among patients with ER positive and PR positive primary tumors: 122 of 190 individuals (64%) with ER positive tumors had the variant allele versus 25 of 54 patients (46%) with ER negative tumors (p = 0.001), and 104 of 160 individuals (65%) with PR positive tumors versus 41 of 82 subjects (50%) of those with PR negative tumors (p = 0.001). Furthermore, the AG and AA genotypes were more frequent among patients with well to moderately differentiated tumors (76 of 116 individuals (66%) versus 49 of 96 subjects (51%) with poorly differentiated tumors; p = 0.001). The variant allele was also more frequent among LN negative patients when compared with LN positive patients (81 of 125 patients (65%) with no positive LN versus 65 of 123 individuals (53%) with >/=1 LN; p = 0.033). No significant differences were observed with respect to primary tumor size and variant allele status did not influence disease-free survival in this cohort. Multivariate analysis that included age at diagnosis as covariate confirmed these results (Table 2), which again demonstrated that the variant allele was associated with a number of indicators of improved outcome.
###end p 41
###begin p 42
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
Genotype and Allele Frequency of RRP1B 1421G-->A SNP in the Orange County Cohort by Tumor Characteristic: Univariate and Multivariate Analyses
###end p 42
###begin title 43
Analysis in a Breast Cancer Cohort from the Greater Baltimore Area
###end title 43
###begin p 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 185 194 185 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st011">Table S11</xref>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t003">Table 3</xref>
###xml 769 777 769 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t002">Tables 2</xref>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030214-t003">3</xref>
###xml 1273 1281 1271 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g005">Figure 5</xref>
###xml 1769 1774 1767 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
###xml 1466 1474 <span type="species:ncbi:9606">Patients</span>
###xml 1545 1553 <span type="species:ncbi:9606">patients</span>
###xml 1686 1694 <span type="species:ncbi:9606">patients</span>
RRP1B SNP analysis was performed in a second small pilot cohort consisting of 248 surgical breast cancer patients (58% African-American, 42% Caucasian) from the greater Baltimore area (Table S11) to attempt to replicate the findings of the initial cohort study. Stratification on race/ethnicity and age at disease onset in the Baltimore cohort indicated that neither of these variables was a significant confounding factor. Consistent with the Orange County cohort, the variant A allele was less frequent in patients with a high stage or poor grade tumor, with ER negative or PR negative tumors, and with a LN positive disease (Table 3). Most associations between the A allele and tumor markers were best explained by assuming an additive effect of the variant allele (Tables 2 & 3), however, studies in larger populations are required to better define the relative effect of the variant allele on outcome markers in breast cancer. We also examined the association between the 1421G-->A SNP and breast cancer survival by assuming a dominant effect of the variant allele on survival, a model that best reflects our survival data. Carriers of the variant allele had a significantly better breast cancer-specific survival compared to homozygous carriers of the common allele (Figure 5). Multivariate Cox regression analysis with adjustments for age at diagnosis, race, ER status, tumor-node-metastasis (TNM) stage, and chemotherapy, further confirmed this observation. Patients who carried the variant allele had improved survival when compared to patients with the G/G genotype (hazard ratio of death (HR) = 0.46; 95% confidence interval (CI) = 0.21-0.97). This effect was stronger among patients with an ER positive tumor (HR = 0.17; 95% CI = 0.04-0.70) suggesting that RRP1B may have a particular function in the ER pathway.
###end p 44
###begin p 45
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
Association of Tumor Characteristics with the RRP1B 1421G-->A SNP in the Baltimore Cohort
###end p 45
###begin title 46
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
RRP1B 1421G-->A SNP and Breast Cancer Survival
###end title 46
###begin p 47
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Kaplan-Meier survival analysis. The survival of patients with the variant allele (A/G or A/A; n = 92) is significantly better than the survival of patients who are homozygous carriers of the common allele (G/G; n = 150). Two-sided log-rank test: p = 0.025.
###end p 47
###begin title 48
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
Haplotype Analysis of the RRP1B Pro436Leu Variant
###end title 48
###begin p 49
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 934 935 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The Pro436Leu SNP was selected for analysis in the pilot epidemiology analysis due to its potential effect on RRP1B function as the result of the nonsynonymous amino acid substitution. The pilot epidemiology data, while consistent with the possibility of role of RRP1B in breast cancer progression, does not distinguish between causal polymorphisms and polymorphisms in high linkage disequilibrium (LD) with the causal variant. To gain a better understanding of whether the Pro436Leu SNP might be the causal variant effecting RRP1B function, haplotype analysis was performed using the publicly available HapMap data (). rs9306160 was genotyped on the 30 CEPH trios (90 samples) used in the HapMap project and the linkage disequilibrium (LD) structure determined. Analysis of the current version of the HapMap revealed that the Pro436Leu SNP was in a large haplotype block spanning 212,658 bp, with 40 SNPs in high LD with rs9306160 (r2 > 0.8). The haplotype block encompasses only two genes, RRP1B and HSF2BP. Among the 673 SNPs in this region rs9306160 is the only missense polymorphism within this haplotype block based on RefSeq annotation (), and therefore remains an interesting candidate for the causative polymorphism. However, we cannot exclude at this time the possibility that the causative effect is due to a different linked polymorphism. Further analysis at the epidemiology and molecular level will be required to resolve this question.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b021">21</xref>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 330 336 <span type="species:ncbi:9606">humans</span>
The diverse techniques employed in this study, including genetical genomics [21], functional genomics, sequence analysis, and molecular epidemiology, have allowed us to identify Rrp1b as a candidate for both a tumor progression and metastasis modifier in mice, and a marker of inherited breast cancer metastasis susceptibility in humans. Furthermore, functional data provides evidence that Rrp1b regulates ECM gene expression, and that a nonsynonymous SNP in RRP1B is associated with tumor progression and disease-specific survival in pilot epidemiology experiments.
###end p 51
###begin p 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 611 612 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b009">9</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b011">11</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b022">22</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b012">12</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 1053 1058 1053 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1099 1100 1099 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b006">6</xref>
###xml 1206 1211 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1322 1327 1322 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 263 268 <span type="species:ncbi:4932">Yeast</span>
###xml 603 609 <span type="species:ncbi:9606">humans</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 863 868 <span type="species:ncbi:10090">mouse</span>
Rrp1b was identified through two distinct experimental approaches designed to address two independent questions: (a) what is the molecular mechanism(s) by which Sipa1 modulates metastasis, and (b) what drives ECM dysregulation in metastasis-prone primary tumors? Yeast two-hybrid assays and functional genomic studies addressed the first question, which identified Rrp1b as binding to the polymorphic PDZ domain of Sipa1. The second question probed the origins of metastasis-predictive gene expression signatures. ECM genes are components of all metastasis-predictive gene expression signatures in both humans [9-11,22] and mice [12,13], a finding that may well be explained in part by constitutional variation [13]. To test this question, we examined whether ECM eQTLs and metastasis modifiers might be the same entities by analyzing ECM gene expression in a RI mouse panel. This led to the identification of several eQTLs, with a locus on proximal chromosome 17 displaying the strongest linkage. The peak linkage region of this locus encompasses both Rrp1b and a tumor growth and progression QTL [6], and rather remarkably, when we examined expression of transcripts within the peak eQTL linkage region, Rrp1b was highly correlated with metastasis-predictive ECM gene expression. Taken together, these data suggest that Rrp1b is a potential dual ECM and tumor progression candidate.
###end p 52
###begin p 53
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b009">9</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1149 1154 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
Further experimentation demonstrated that ectopic expression of Rrp1b in two highly metastatic mammary tumor cell lines and a mouse fibroblast cell line modulates ECM gene expression, a finding concurrent with our initial hypothesis that Rrp1b is indeed the chromosome 17 ECM eQTL. It should be noted however, that the directionality of the ECM expression changes observed in response to Rrp1b activation in these cell lines are not directly comparable to the changes in ECM expression observed in metastasis-predictive gene expression signatures [9-13]. Primary tumors are composed of a variety of cell and tissue types, and this cellular and microenvironmental heterogeneity is not accurately reflected by in vitro growth conditions of single cell types. Nevertheless, we do argue that our in vitro experimentation demonstrates that Rrp1b modulates the expression of metastasis-predictive ECM genes in a variety of individual cell lines. It is also evident that further work will be necessary to define the complex microenvironmental relationships that modulate ECM gene expression in bulk tumor tissue and their relationship to overall levels of Rrp1b activation.
###end p 53
###begin p 54
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 1107 1112 <span type="species:ncbi:10090">mouse</span>
In addition, it should be noted that eQTL analysis is most commonly associated with expression changes in normal tissues, and not the neoplastic tissues analyzed in this study. However, eQTLs owe their existence to germline polymorphism, and such variation will be present in tumor tissue in addition to normal tissues. With this in mind, it is therefore not unreasonable to assume that the phenotypic effects of eQTLs will be observed in tumors as well as normal tissue. Yet neoplastic tissues possess an inherent genomic instability, and it is therefore possible that variations in tumor gene expression patterns could also arise from somatic mutation. However, we have demonstrated that eQTLs can be genetically mapped in tumors, which suggests either that similar somatic mutations consistently occur in the majority of the tumor tissue in a subset of the RI strains, or that the observed eQTLs result from inherited polymorphisms. Our previous demonstration that the same ECM genes used to define tumor eQTLs are differentially expressed in normal mammary tissues derived from high- and low-metastatic mouse genotypes [13] suggests that such differential expression may be partially regulated by germline polymorphism. At this stage, however, we cannot formally dismiss a role for somatic mutation in ECM gene expression variation within RI mammary tumors.
###end p 54
###begin p 55
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 823 828 823 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 501 506 <span type="species:ncbi:10090">mouse</span>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 796 801 <span type="species:ncbi:10090">mouse</span>
We also described a number of important functional differences in Rrp1b between the progenitors of the AKXD RI panel, the high metastatic AKR/J, and low metastatic DBA/2J genotype mice. Specifically, the proximal promoter of Rrp1b in AKR/J mice contained polymorphisms that may reduce Rrp1b expression. This difference in promoter activity is one possible explanation for the observed differences in Rrp1b expression in the normal mammary tissue of these mice, with the high metastatic capacity AKR/J mouse having significantly lower levels of Rrp1b activity than the low metastatic DBA/2J mouse. Furthermore, ectopic expression led to reduced metastatic potential and primary tumor growth following tumor cell implantation into mice. In combination, these observations suggest, at least in this mouse model that increased Rrp1b expression correlate with a better outcome.
###end p 55
###begin p 56
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b020">20</xref>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b010">10</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b010">10</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b023">23</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b024">24</xref>
###xml 1152 1157 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 733 741 <span type="species:ncbi:9606">patients</span>
###xml 924 931 <span type="species:ncbi:9606">patient</span>
###xml 1130 1138 <span type="species:ncbi:9606">patients</span>
We have used a dual approach to try to address the importance of RRP1B in human breast cancer progression. The first of these approaches was to use data derived from microarray expression analysis of the Mvt-1/Rrp1b cells to address one of the central goals of our research: the translation of experimental data from mouse models of human breast cancer into potentially clinically relevant observations. Based on the work of Bild et al. [20] we identified an RRP1B gene expression signature and demonstrated it that predicts outcome in a publicly available and well-characterized breast cancer cohort [10]. This gene signature not only held strong prognostic value in the Dutch study cohort [10], but was also able to stratify those patients with ER positive tumors and LN negative disease at presentation into high and low risk categories. There has been significant interest in using gene expression profiles for improved patient stratification [23,24] in the clinic since it raises the possibility of improvements in breast cancer subtype classification, which in turn could enable clinicians to tailor treatment to individual patients. Whether the RRP1B signature proves of clinical value in this respect is at present unclear, and further testing of its prognostic value in different cohorts will be required to address this possibility. The significance of this study, however, is not the identification of yet another prognostic signature, but the fact that the underlying casual element is known. Identification of other genetic elements that drive the predictive gene expression patterns may provide a more robust means of complementing currently available tests used for the assessment of prognosis in breast cancer. Furthermore, this type of study also provides us with potentially novel and important insights into the mechanisms underlying the metastatic process.
###end p 56
###begin p 57
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 229 234 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 560 565 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 581 586 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 989 994 981 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1062 1067 1054 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1803 1808 1793 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 356 364 <span type="species:ncbi:9606">patients</span>
###xml 611 616 <span type="species:ncbi:9606">human</span>
###xml 810 818 <span type="species:ncbi:9606">patients</span>
###xml 926 933 <span type="species:ncbi:9606">patient</span>
Further supportive evidence for the role of RRP1B in human breast cancer progression was evident in the two pilot epidemiological studies, both of which found an inverse relationship between the variant A allele of the 1421G-->A RRP1B SNP and poor outcome markers. These consistent findings indicate that 1421G-->A is a marker for disease progression, and patients who carry the A allele are less likely to present with advanced disease than homozygous carriers of the more common G allele. These data are consistent with the results of functional analysis of Rrp1b, and associate RRP1B with disease outcome in human breast cancer. It should be noted that the variant 1421G-->A allele was associated with improved outcome in those individuals with ER positive tumors, which may permit better stratification of patients who are currently thought to be in a low risk category. A particularly intriguing question is if and how a patient's 1421G-->A genotype affects expression of the 33-gene RRP1B expression signature, and whether polymorphisms in the promoter of RRP1B in linkage disequilibrium with the 1421G-->A SNP are more important in this respect. These studies are currently ongoing in this laboratory. Indeed, a link between constitutional polymorphism and bulk tumor gene expression would be particularly significant given the technical difficulties associated with tumor gene expression profiling and the relative ease of SNP genotyping. These results, while consistent between the studies and in support of our hypothesis, must be considered only as preliminary. Further investigations in larger epidemiology studies specifically designed to address tumor progression and outcome, rather than tumor incidence, will be necessary to gain further support for the role of germline polymorphism in RRP1B in breast cancer progression.
###end p 57
###begin p 58
###xml 303 304 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1582 1584 1580 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b025">25</xref>
###xml 1720 1725 1716 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 541 549 <span type="species:ncbi:9606">patients</span>
###xml 711 719 <span type="species:ncbi:9606">patients</span>
###xml 869 874 <span type="species:ncbi:9606">women</span>
###xml 1036 1044 <span type="species:ncbi:9606">patients</span>
###xml 1510 1515 <span type="species:ncbi:9606">women</span>
###xml 1572 1580 <span type="species:ncbi:9606">patients</span>
Several differences were evident between the epidemiology study cohorts, the most notable of which was that the 1421G-->A SNP was associated with breast cancer-specific survival only in the Baltimore cohort, a discrepancy that is likely due to several factors. First, both cohorts are relatively small (n < 300), thus some differences might arise from statistical power issues. More importantly, the study population compositions differed: the Orange County cohort was derived from a population-based case-cohort study, including all cancer patients, regardless of stage, with more than 10 years of follow up, whereas the Baltimore cohort is a surgical breast cancer population, and therefore is biased against patients with metastatic disease at presentation. Furthermore, unlike the Orange County cohort, the Baltimore cohort contained African-American and Caucasian women. Differences in race/ethnicity influence allele frequency and disease outcome, and some variability in results is therefore expected. While the participation of patients from different race/ethnicities also strengthens study design, stratification is required. Stratification on race/ethnicity in the Baltimore cohort indicated that race/ethnicity was not a significant confounding factor. It is interesting to note, however, that the variant allele distribution is different in African-Americans and Caucasians in the Greater Baltimore cohort (0.099 in African-Americans versus 0.411 in Caucasians). It is known that African-American women have a poorer prognosis compared to other breast cancer patients [25], and given the protective effect exerted by the variant 1421G-->A, it is interesting to speculate that polymorphisms in genes such as RRP1B may be driving these ethnicity-specific differences in outcome. Thus, further characterization of this SNP in larger and ethnically diverse cohorts is required to determine the influence of race/ethnicity upon the association between this SNP and breast cancer survival.
###end p 58
###begin p 59
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b026">26</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b027">27</xref>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b028">28</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b029">29</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b030">30</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b031">31</xref>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 1337 1343 1337 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B.</italic>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 1088 1093 <span type="species:ncbi:9606">human</span>
###xml 1140 1145 <span type="species:ncbi:10090">mouse</span>
###xml 1257 1262 <span type="species:ncbi:9606">human</span>
###xml 1290 1295 <span type="species:ncbi:10090">mouse</span>
The function of Rrp1b and its exact role in metastasis remain unclear at this time. Sipa1 was originally cloned as a mitogen-inducible protein [26] that was subsequently shown to be a negative regulator of Rap1 by serving as a GAP for Rap1 [27]. Sipa1 has significant effects on cellular adhesion [28], primarily related to its effects on Rap1, which has been implicated in maintaining the integrity of polarized epithelia [29] and intercellular adherens junctions [30], and potentially integrating signaling between cadherins and integrins [31]. Rrp1b may therefore mediate tumor cell adhesion properties by altering intercellular and cell-ECM contacts in a Sipa1-dependent and Rap1-dependent manner. It should be noted, however, that the human polymorphism in RRP1B falls outside of the domain that directly interacts with the PDZ domain of Sipa1. Whether this polymorphism impacts the enzymatic function of Sipa1 or mediates metastatic potential through some other mechanism is unclear and currently under investigation. Similarly, it is unclear whether the amino acid substitution in human RRP1B directly affects function. Based on the mouse model, where increased expression confers protection against malignant progression, the variant leucine in the human ortholog may phenocopy the mouse situation by activating some function of RRP1B. Further in vitro analysis will be required to clarify the different situations in the two species and is currently under investigation in our laboratory.
###end p 59
###begin p 60
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b032">32</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b033">33</xref>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b034">34</xref>
###xml 945 950 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 955 960 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 291 296 <span type="species:ncbi:4932">yeast</span>
###xml 601 607 <span type="species:ncbi:9606">humans</span>
###xml 683 691 <span type="species:ncbi:9606">patients</span>
###xml 964 969 <span type="species:ncbi:9606">human</span>
In addition to the negative regulatory role on Sipa1 function, there is some evidence to suggest that Rrp1b may be involved in RNA metabolism. Protein homology analysis has shown Rrp1b to contain a Nop52 domain, a motif found in proteins critical to 28S rRNA generation [32], and a previous yeast two-hybrid analysis has shown that Rrp1b may also interact with Lsm1, which is a protein involved in regulation of mRNA degradation [33]. Publicly available databases show that RRP1B is ubiquitously expressed at a somewhat low level, although it is expressed at a slightly higher level in lymph nodes in humans (). Differential expression of RRP1B has been reported in fibroblasts from patients with systemic sclerosis, an autoimmune disorder characterized by dysregulation of a variety of ECM genes, including procollagens I, III, and VI [34], consistent with our results. Further research, however, is clearly needed to fully explore the role of Rrp1b and Sipa1 in human breast cancer and other tumor types. Unraveling the mechanisms of action and the molecular pathways that they regulate are likely to provide novel and valuable insights into tumor dissemination and metastasis.
###end p 60
###begin title 61
Materials and Methods
###end title 61
###begin title 62
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid analysis.
###end title 62
###begin p 63
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Yeast two-hybrid screens using different regions of the human Sipa1 protein (Entrez Gene ID No: 6494) as bait were performed by ProNet technology (Myriad Genetics, Salt Lake City, UT). Methodology for these commercially performed experiments is provided by Myriad Genetics and is available in Text S2.
###end p 63
###begin title 64
Coimmunoprecipitation of Rrp1b with Sipa1.
###end title 64
###begin p 65
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b007">7</xref>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 1135 1146 <span type="species:ncbi:3704">horseradish</span>
###xml 1174 1180 <span type="species:ncbi:9986">rabbit</span>
###xml 1187 1192 <span type="species:ncbi:10090">mouse</span>
###xml 1202 1206 <span type="species:ncbi:9925">goat</span>
The various genes were cloned into pcDNA3. HEK293 (293) cells were transiently transfected with lipofectamine (Invitrogen) according to the manufacturer's instructions. They were cotransfected with pcDNA3 vector or mouse Sipa1-V5 from DBA [7], and Rrp1b-V5, Rrp1b-HA, or AQP2 (from American Type Culture Collection). Two days after transfection, cells were lysed with Golden Lysis Buffer (GLB) containing 20 mM Tris (pH 7.9), 137 mM NaCl, 5 mM EDTA, 1 mM EGTA, 10 mM NaF, 10% Glycerol, 1% Triton X-100, 1 mM sodium pyrophosphate, 1 mM leupeptin, 1 mM PMSF, and aprotinin (10 mug/ml). Cell extracts were immunoprecipitated with anti-Spa-1 (Sipa1) mAb (BD BioSciences), and protein A/G Sepharose (Pierce) were added and rotated overnight at 4 degreesC. The immune complexes were washed once with GLB, once with high salt HNTG (20 mM Hepes, 500 mM NaCl, 0.1% Triton X-100, 10% Glycerol), and twice with low salt of HNTG (20 mM Hepes, 150 mM NaCl, 0.1% Triton X-100, 10% Glycerol). The immune complexes were then analyzed by immunoblotting with antibodies against AQP2 (Santa Cruz), V5 (Invitrogen), or HA (Convance). For each immunoblot, horseradish peroxidase-conjugated anti-rabbit, anti-mouse, or anti-goat immunoglobulin G was used for the second reaction at a 1:10,000 dilution. Immunoblots were visualized by enhanced chemiluminescence with an ECL Kit (Amersham).
###end p 65
###begin title 66
RALGDS pull-down assay.
###end title 66
###begin p 67
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
293 cells were transiently cotransfected with pcDNA3 vector or mouse Sipa1 and Rrp1b-V5 or AQP2. Epac-HA was also cotransfected, to elevate the level of Rap1-GTP, and pcDNA3 vector was added as necessary to ensure that equal amounts of DNA were transfected. Transfected cells were processed two days later, using a Rap1 activation Kit (Upstate Biotech) according to the manufacturer's instructions. Equal amounts of the total protein from cell extracts were estimated based on BCA protein assay kit (Pierce). Rap1-GTP protein was pulled down by RalGDS-RBD beads and washed three times, then subjected to gel analysis and immunoblotting using anti-Rap1 antibody (Santa Cruz). Cell extracts from transfectants were analyzed for protein expression by immunoblotting, using anti-AQP2 antibody, anti-Spa-1 mAb, or anti-V5 antibody.
###end p 67
###begin title 68
Cell culture.
###end title 68
###begin p 69
###xml 224 230 <span type="species:ncbi:9913">bovine</span>
The Mvt-1 and 4T1 cell lines were obtained as a gift from Lalage Wakefield (National Cancer Institute, Bethesda). The cells were cultured in Dulbecco's Modification of Eagle's Medium (DMEM; Cellgro, VA) containing 10% fetal bovine serum (FBS; Cellgro, VA), with culture medium being replaced at three day intervals. When the cells achieved confluency, they were washed once with 5 ml phosphate-buffered saline (PBS), incubated with 2 ml trypsin-EDTA for 5 min, and passaged at a 1:30 dilution into a fresh culture flask. NIH-3T3 cells were maintained in the same manner as Mvt-1, except cells were passaged at a 1:15 ratio when they achieved confluency.
###end p 69
###begin title 70
Expression QTL mapping.
###end title 70
###begin p 71
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b015">15</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b013">13</xref>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp16</italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mfap5</italic>
###xml 521 529 521 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serpinf1</italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbn1</italic>
###xml 563 571 563 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serping1</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnxb</italic>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col3a1</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nid1</italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbln2</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Timp2</italic>
###xml 856 857 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b009">9</xref>
###xml 879 885 879 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 918 924 918 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a2</italic>
###xml 768 773 <span type="species:ncbi:9606">human</span>
Microarray hybridization methodology and generation of the microarray expression data from AKXD x PyMT primary tumors has been described previously [13]. Affymetrix .CEL files were normalized using the RMA method, averaged for each AKXD RI strain, and loaded into the GeneNetwork web service () [15]. The database was then searched for the 11 probe sets from our previously described metastasis signature profile [13] classification as within an "ECM component" (1437568_at, Mmp16; 1418454_at, Mfap5-pending; 1416168_at, Serpinf1; 1425896_a_at, Fbn1; 1416625_at, Serping1; 1450798_at, Tnxb; 1439364_a_at, Mmp2; 1427884_at, Col3a1; 1416808_at, Nid1; 1423407_a_at, Fbln2; and 1420924_at, Timp2). Additionally, a further five probe sets for the ECM genes represented the human breast carcinoma metastasis gene signature profile described by Ramaswamy et al. [9] were also included (Col1a1: 1423669_at_A, 1455494_at_A and Col1a2: 1423110_at_A, 1446326_at_B, 1450857_a_at_A). eQTLs were defined as described above.
###end p 71
###begin title 72
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b.</italic>
Development of Mvt-1 and 4T1 clonal isolates ectopically expressing Rrp1b.
###end title 72
###begin p 73
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 574 575 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 640 645 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1270 1275 1262 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
An expression vector encoding the full length Rrp1b cDNA BC016569 in pCMV-SPORT6 was obtained from the Mammalian Gene Collection (MGC:27793, IMAGE ID: 3157173). The control cell line was generated using the vector pCMV-SPORT-beta-Galactosidase (Invitrogen). The identity of the vector was sequence verified before transfection. Supercoiled plasmids were transfected into Mvt-1 and 4T1 cells using Superfect Transfection Reagent (Qiagen, Valencia, CA) as per the manufacturer's instructions. Briefly, transfections were performed in 100 mm diameter culture dishes, with 2 x106 Mvt-1 or 4T1 cells being seeded 24 h prior to transfection. The Rrp1b-pCMV-Sport6 and pCMV-SPORT-beta-Galactosidase vectors were cotransfected with the vector pSuper.Retro.Puro (Oligoengine) containing no insert as a selectable marker for transfectants. Cells in each culture vessel were transfected with a total of 20 mug vector DNA using Superfect at a 6:1 lipid to DNA ratio. Twenty-four hours after transfection, the cells were selected in normal growth medium containing 10 mug/ml puromycin (Sigma Aldrich), transferred to 96 well plates, and individual clones were selected by limiting dilution. Colonies were screened by qPCR as described below to identify clones ectopically expressing Rrp1b.
###end p 73
###begin p 74
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1124 1129 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
With regards to the NIH-3T3 cell lines, PCR primers were designed to encompass the entire length of the Rrp1b cDNA BC016569. The following primer sequences generated a 2,248 bp product from normal mammary tissue cDNA, with the downstream primer being designed to omit the transcription termination codon and to remain in coding frame: 5'-CCCATACGCAGACGCAGT-3' and 5'-GAAGAAGTCCGCAGCCCT-3'. Full length Rrp1b cDNA was then amplified using rTth DNA Polymerase, XL (Applied Biosystems) as per the manufacturer's protocol. Following PCR amplification, Rrp1b cDNA was inserted into the reporter vector pcDNA3.1 V5-His using a pcDNA3.1 V5-His TOPO(R) Cloning Kit (Invitrogen) and transformed into TOP10 competent cells (Invitrogen) as per the manufacturer's protocol. Plasmids were propagated in 100 ml LB Medium containing 100mug/ml ampicillin. Plasmid DNA was extracted using a Qiagen EndoFree Maxi Kit, and insert identity and integrity of the full-length sequence was verified prior to further experimentation. Transfection of this vector into NIH-3T3 cells was performed in the same manner as for Mvt-1 cells except that the Rrp1b construct was cotransfected with the puromycin selection marker pPur (Clontech), and selection of transformants performed using 5 mug/ml puromycin and 700 mug/ml G418 (Sigma Aldrich).
###end p 74
###begin title 75
Total RNA isolation for qPCR.
###end title 75
###begin p 76
###xml 468 471 468 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
###xml 473 476 473 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">280</sub>
Total RNA samples were isolated from cell culture samples using an RNeasy Mini Kit (Qiagen) with sample homogenization being performed using a 21 gauge needle and syringe as per the manufacturer's protocol. All samples were subjected to on-column DNase digestion, and RNA quality and quantity determined by an Agilent Technologies 2100 Bioanalyzer (Bio Sizing Software version A.02.01, Agilent Technologies). Only those samples containing high-quality total RNA with A260/A280 ratios between 1.8 and 2.1 were used for further analysis.
###end p 76
###begin title 77
Quantitative Real-Time PCR gene expression analysis.
###end title 77
###begin p 78
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 575 584 575 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st012">Table S12</xref>
###xml 756 782 756 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">peptidylprolyl isomerase B</italic>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppib</italic>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st012">Table S12</xref>
cDNA was synthesized from RNA isolated from either primary tumor tissues or transfected cell lines using the ThermoScript RT-PCR System (Invitrogen, Carlsbad, CA) by following the manufacturer's protocol. Single RT-PCRs were performed for each Mvt-1 and 4T1 clonal isolates, and in triplicate for the untransfected or Rrp1b-expressing NIH-3T3 total RNAs. SYBR Green qPCR was performed to detect the cDNA levels of Rrp1b and a variety of metastasis predictive ECM genes (see above) using an ABI PRISM 7500 and/or 7900HT Sequence Detection Systems and custom designed primers (Table S12). Reactions were performed using QuantiTect SYBR Green Master Mix (Qiagen, Valencia, CA) as per the manufacturer's protocol. The cDNA level of each gene was normalized to peptidylprolyl isomerase B (Ppib) cDNA levels using custom-designed primers for SYBR green-amplified target genes (Table S12).
###end p 78
###begin title 79
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Sequencing of the Rrp1b gene.
###end title 79
###begin p 80
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b035">35</xref>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st004">Table S4</xref>
###xml 771 773 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b036">36</xref>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
Complete sequencing of the exons, intron-exon boundaries, promoters, and the regions immediately upstream of the promoters was performed in two highly metastatic (AKR/J, FVB/NJ) and three low metastatic (DBA/2J, I/LnJ, NZB/B1NJ) strains of mice [35]. The sequences of the primers for Rrp1b are shown in Table S4. PCR products were generated under standard amplification conditions (5 min at 94 degreesC, 30 s at 57 degreesC, 30 s at 72 degreesC, and 5 min at 72 degreesC), purified with a Qiagen PCR purification kit, and double strand sequencing performed with a Perkin Elmer BigDye Terminator sequence kit. Analysis was performed on a Perkin Elmer 3100 Automated Fluorescent Sequencer. Sequences were compiled and analyzed with the computer software package VectorNTI [36].
###end p 80
###begin title 81
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Generation of Rrp1b proximal promoter beta-galactosidase reporter constructs.
###end title 81
###begin p 82
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
PCR primers were designed to encompass the two proximal promoter polymorphisms identified by sequencing Rrp1b. The following primer sequences generated a 1,672 bp product with AKR/J genomic DNA and a 1,670 bp product with DBA/2J: 5'-AACCTCATCGTCCCTTGG-3' and 5'-GCACTCGCTTCAGCATCC-3'. Proximal promoter sequences were amplified using rTth DNA Polymerase, XL (Applied Biosystems) as per the manufacturer's protocol. Following PCR amplification, proximal promoter sequences were inserted into the reporter vector pBlue TOPO using a pBlue TOPO(R) TA Expression Kit (Invitrogen) and transformed into TOP10 competent cells (Invitrogen) as per the manufacturer's protocol. Plasmids were propagated in 100 ml of Luria-Bertani Medium containing 100 mug/ml ampicillin. Plasmid DNA was extracted using a Qiagen EndoFree Maxi Kit. AKR/J and DBA/2J promoter constructs were sequence verified prior to further experimentation as described above.
###end p 82
###begin title 83
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Quantification of activity of Rrp1b proximal promoter beta-galactosidase reporter constructs.
###end title 83
###begin p 84
###xml 241 242 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 319 324 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1168 1171 1150 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">562</sub>
Supercoiled plasmids were transfected into NIH-3T3 cells using Superfect Transfection Reagent (Qiagen, Valencia, CA) as per the manufacturer's instructions. Briefly, transfections were performed in 100 mm diameter culture dishes, with 2 x 106 NIH-3T3 cells seeded 24 h prior to transfection with 10mug vector DNA (8mug Rrp1b promoter construct and 2mug of pGL3-Control (Promega)) using Superfect at a 5:1 lipid to DNA ratio. Transfections were performed in triplicate for each promoter construct. Twenty-four hours after transfection, the cells were washed with PBS, trypsinized, collected, and washed twice with cold PBS. Cell lysis was achieved using 100 mul of lysis buffer per 100 ml plate from a beta-Galactosidase Assay Kit (Invitrogen). beta-galactosidase activity in each sample was assayed as per the manufacturer's protocol using either 20 mul or 30 mul of the lysate. The remaining lysate was used to determine lysate protein concentration, which was assayed using a BCA Assay Kit (Pierce). beta-galactosidase activity was calculated for each sample as per the beta-Galactosidase Assay Kit (Invitrogen), but is essentially based upon the concentration and A562 of each lysate. These specific activities were normalized against firefly luciferase activity as driven by the pGL3 control vector to account for differing transfection efficiencies. The activity of firefly luciferase for each sample was assayed using a Dual-Luciferase Reporter Assay Kit (Promega) and quantification performed by VICTOR2 (Perkin-Elmer Life Sciences).
###end p 84
###begin title 85
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Quantification of Rrp1b expression in normal mammary tissue.
###end title 85
###begin p 86
###xml 71 74 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 388 391 386 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
###xml 393 396 391 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">280</sub>
###xml 652 657 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 747 752 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 861 887 859 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Peptidylprolyl Isomerase B</italic>
###xml 889 893 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppib</italic>
###xml 922 927 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1002 1011 1000 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030214-st012">Table S12</xref>
Total RNA extractions from tissue samples were carried out using TRIzol(R) Reagent (Life Technologies, Inc.) according to the standard protocol. RNA quantity and quality were determined by the Agilent Technologies 2100 Bioanalyzer (Bio Sizing Software version A.02.01, Agilent Technologies) and/or the GeneQuant Pro (Amersham Biosciences). Samples containing high-quality total RNA with A260/A280 ratios between 1.8 and 2.1 were purified with the RNeasy Mini Kit (Qiagen). An on-column genomic DNA digestion was performed as part of this purification step using the RNase-Free DNase Kit (Qiagen). TaqMan qPCR was performed to detect the cDNA levels of Rrp1b using an ABI PRISM 7500 Sequence Detection System (Applied Biosystems, Foster City, CA). Rrp1b expression was quantified using the Applied Biosystems Assay-On-Demand Mm00551206_m1. The housekeeping gene Peptidylprolyl Isomerase B (Ppib), used for normalization of Rrp1b expression between samples, was quantified using the primers described in Table S12 and the following fluorogenic probe: 6FAM-TCTATGGTGAGCGCTTC-MGB. Reactions were performed using TaqMan Universal PCR Mastermix (Applied Biosystems) per the manufacturer's protocol.
###end p 86
###begin title 87
Spontaneous metastasis assays.
###end title 87
###begin p 88
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 768 769 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
Transfected cells proven to be stably expressing Rrp1b were subcutaneously implanted into virgin FVB/NJ mice. Two days before injection, cells were passaged and permitted to grow to 80%-90% confluence. The cells were then washed with PBS and trypsinized, collected, washed twice with cold PBS, counted in hemocytometer, and resuspended at 106 cells/ml. One hundred thousand cells (100 mul) were injected subcutaneously in the vicinity of the fourth mammary gland of 6-wk-old virgin FVB/NJ female mice. The mice were then aged for 4 wk before they were killed by anesthetic overdose. Tumors were dissected and weighed. Lungs were isolated and surface metastases enumerated using a dissecting microscope. Tumor growth and metastasis was compared to mice injected with 105 Mvt-1 cells stably cotransfected with pCMV-Sport-beta-Gal and pSuper.Retro.Puro. These experiments were performed in compliance with the National Cancer Institute's Animal Care and Use Committee guidelines.
###end p 88
###begin title 89
SNP genotyping.
###end title 89
###begin p 90
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 197 199 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b037">37</xref>
###xml 256 259 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 412 417 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 1277 1282 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
The Rrp1b 1421G-->A polymorphism was characterized using SNP-specific PCR. PCR primers were designed using Primer Express software (Applied Biosystems) according to parameters described elsewhere [37]. Each probe was labeled with a reporter dye (either VIC(R), a proprietary fluorescent dye produced by Applied Biosystems, or FAM, 5-(&6)-carboxyfluorescein) specific for the wild-type and variant alleles of the Rrp1b SNP. Sequences of PCR primers are as follows: 5'-TGGACGTGGCCTCTGCAC-3' and 5'-CACCACCTGCAGCCTGAAA-3'; and the sequences of fluorogenic probes are as follows: 6FAM-AGGGCTTTCAGCCCAGAG and VIC-AGGGCTTTCGGCCCAG. Reaction mixtures consisted of 300 nM of each oligonucleotide primer, 100 nM fluorogenic probes, 8 ng template DNA, and 2x TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) in a total volume of 10 mul. The amplification reactions were performed in a MJ Research DNA Engine thermocycler (Bio-Rad, Hercules, CA) with two initial hold steps (50 degreesC for 2 min, followed by 95 degreesC for 10 min) and 50 cycles of a two-step PCR (92 degreesC for 15 s, 60 degreesC for 1 min). The fluorescence intensity of each sample was measured post-PCR in an ABI Prism 7500 sequence detection system (Applied Biosystems, Foster City, CA), and Rrp1b SNP genotypes were determined by the fluorescence ratio of the nucleotide-specific fluorogenic probes.
###end p 90
###begin title 91
RNA extraction and processing for Affymetrix GeneChip analysis
###end title 91
###begin p 92
Total RNA was extracted using TRIzol Reagent (Life Technologies) according to the standard protocol. Total RNA samples were subjected to DNase I treatment, and sample quantity and quality determined as described above. Purified total RNA for each clonal isolate were then pooled to produce a uniform sample containing 8 mug of RNA.
###end p 92
###begin p 93
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b038">38</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b039">39</xref>
###xml 744 749 <span type="species:ncbi:10090">Mouse</span>
Double stranded cDNA was synthesized from this preparation using the SuperScript Choice System for cDNA Synthesis (Invitrogen) according to the protocol for Affymetrix GeneChip Eukaryotic Target Preparation. The double stranded cDNA was purified using the GeneChip Sample Cleanup Module (Qiagen). Synthesis of biotin-labeled cRNA was obtained by in vitro transcription of the purified template cDNA using the Enzo BioArray High Yield RNA Transcript Labeling Kit (T7) (Enzo Life Sciences). cRNAs were purified using the GeneChip Sample Cleanup Module (Qiagen). Hybridization cocktails from each fragmentation reaction were prepared according to the Affymetrix GeneChip protocol. The hybridization cocktail was applied to the Affymetrix GeneChip Mouse Genome 430 2.0 arrays, processed on the Affymetrix Fluidics Station 400, and analyzed on an Agilent GeneArray Scanner with Affymetrix Microarray Suite version 5.0.0.032 software. Normalization was performed using the BRB-Array Tools software [38,39].
###end p 93
###begin title 94
Microarray and survival analysis.
###end title 94
###begin p 95
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 146 148 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
To generate a high confidence human transcriptional signature of Rrp1b expression, 98 probe sets whose differential expression demonstrated p < 10-7 were selected by matching the gene symbols from the mouse dataset to the published Hu25K chip annotation files. Analysis of tumor gene expression from breast cancer datasets was performed using BRB ArrayTools. Expression data were downloaded from the Rosetta Company website (). Expression data were loaded into BRB ArrayTools using the Affymetrix GeneChip Probe Level Data option or the Data Import Wizard. Data were filtered to exclude any probe set that was not a component of the Rrp1b signature, and to eliminate any probe set whose expression variation across the data set was p >/= 0.01.
###end p 95
###begin p 96
Unsupervised clustering of each dataset was performed using the Samples Only clustering option of BRB ArrayTools. Clustering was performed using average linkage, the centered correlation metric and center the genes analytical option. Samples were assigned into two groups based on the first bifurcation of the cluster dendogram, and Kaplan-Meier survival analysis performed using the Survival module of the software package Statistica. Significance of survival analyses was performed using the Cox F-test.
###end p 96
###begin title 97
Breast cancer cohorts.
###end title 97
###begin p 98
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orange County, California.</italic>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b008">8</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b040">40</xref>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
Orange County, California. This patient population is a random sample of 269 probands successfully genotyped for the Rrp1b SNP that were diagnosed between March 1, 1994 and February 28, 1995 with invasive breast cancer. Probands were ascertained through the population-based Hereditary Breast Cancer Study funded by the National Cancer Institute. A description of the study and details of data collection methods have been reported previously [8,40]. Briefly, there were two case groups: cases with localized disease (n = 130), and cases with regional/metastatic disease (n = 139). The average age at diagnosis of this cohort was 55.9 +/- 13.4 years, and the average body mass index was 25.7 +/- 4.9.
###end p 98
###begin p 99
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Greater Baltimore, Maryland.</italic>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
###xml 653 661 <span type="species:ncbi:9606">Patients</span>
###xml 689 692 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 694 711 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 716 733 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 899 907 <span type="species:ncbi:9606">patients</span>
Greater Baltimore, Maryland. Surgical breast cancer cases were recruited at the University of Maryland Medical Center, the Baltimore Veterans Affairs Medical Center, Union Memorial Hospital, Mercy Medical Center, and the Sinai Hospital in Baltimore, Maryland between February 15, 1993 and August 27, 2003. We collected blood, tissue specimens, and survival information from 248 patients. These patients had pathologically confirmed breast cancer, were of African-American or Caucasian descent by self-report, were diagnosed with breast cancer within the last six months prior to recruitment, and had, by self-report, no previous history of the disease. Patients were excluded if they were HIV, hepatitis B virus, or hepatitis C virus carriers, were intravenous drug users, were institutionalized, or were physically or mentally unable to sign consent and complete the questionnaire. Of the eligible patients that were identified through surgery lists, 83% participated in the study. The subjects signed a consent form and completed an interviewer-administered questionnaire. Additional information to determine the ER-alpha status, disease stage, treatment, and survival was obtained from medical records and pathology reports, the Social Security Death Index, and the National Death Index. Disease staging was performed according to the TNM system of the American Joint Committee on Cancer/ the Union Internationale Contre le Cancer (AJCC/UICC). The Institutional Review Boards at the participating institutions approved the study.
###end p 99
###begin title 100
Statistical analysis.
###end title 100
###begin p 101
###xml 545 547 545 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 677 679 677 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 1180 1188 <span type="species:ncbi:9606">patients</span>
###xml 1315 1323 <span type="species:ncbi:9606">patients</span>
###xml 1401 1409 <span type="species:ncbi:9606">patients</span>
Student's t-tests were used to compare means for continuous variables and Wilcoxon's sum rank test to compare medians. Variables that were not normally distributed, such as tumor size, were log transformed. Chi-square test or Fisher's exact tests were used to test for differences between categorical variables and to test for Hardy-Weinberg equilibrium. Unconditional logistic regression adjusting for multivariate covariates, such as age at diagnosis, was used to estimate the adjusted odds ratios. We used likelihood ratio tests to calculate p-values comparing a model with covariates to a model without them. We used Cox regression models to perform survival analysis. All p-values presented are two-tailed and were considered to be statistically significant if they were below 0.05. The Kaplan-Meier method and the log-rank test were used for univariate survival analysis and Cox regression models were used to perform multivariate survival analysis. For the Baltimore cohort, survival was determined for the period from the date of hospital admission to the date of the last completed search for death entries in the Social Security Index (August 18, 2004) for the 248 case patients. The mean follow-up time for breast cancer survival was 55 months (range: 12 to 140 months). A total of 59 (24%) of these 248 patients died during this period. We obtained death certificates of the deceased case patients and censored all causes of death that were not related to breast cancer, such as accidents, violent crimes, stroke, heart attack, and liver cirrhosis, in our analysis.
###end p 101
###begin title 102
Haplotype analysis.
###end title 102
###begin p 103
###xml 352 354 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b041">41</xref>
###xml 371 372 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 512 520 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030214-g006">Figure 6</xref>
The genotype data of the 90 HapMap CEPH trio in the 250 kb flanking region of rs9306160 was downloaded from the HapMap database (). A total of 304 SNPs with minor allele frequency >/=10% were selected to evaluate the LD structure. The CEPH genotype data we generated for rs9306160 were integrated with the HapMap data in this analysis. Using LDSelect [41] with a cut of r2 >/= 0.64 we found a large LD block spanning a 210 kb genomic region (chr21:43739961-43952618) that has 104 SNPs in high LD with rs9306160 (Figure 6). In this 210 kb region, there are a total of 673 dbSNP markers and rs9306160 is the only nonsysnonymous SNP based on RefSeq annotation.
###end p 103
###begin title 104
Haplotype Structure Surrounding rs9306160 in the CEPH Families
###end title 104
###begin p 105
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b042">42</xref>
The LD structure of rs9306160. Pairwise r2 values are shown with gray scale; the higher the r2 value the darker the color. The red line and arrow mark the location of rs9306160. The large block in the middle represents the 210 kb LD block where 104 SNPs are in high LD with rs9306160. The figure was generated by the program HaploView [42].
###end p 105
###begin title 106
Supporting Information
###end title 106
###begin title 107
###xml 40 44 <span type="species:ncbi:10090">Mice</span>
Chromosome 17 ECM eQTL Locus in AKXD RI Mice
###end title 107
###begin p 108
###xml 301 302 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030214-b006">6</xref>
###xml 346 351 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
ECM eQTL analysis in AKXD mice revealed that a locus on proximal chromosome 17 influenced the expression of metastasis-predictive ECM genes. The chromosome 17 locus peak linkage region (approximately29.5 Mb) colocalizes with a previously described metastasis efficiency and tumor growth kinetics QTL [6], and encompasses the physical location of Rrp1b (approximately29.9 Mb).
###end p 108
###begin p 109
(255 KB PDF)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin title 111
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Mvt-1/Rrp1b Growth Curve
###end title 111
###begin p 112
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Ectopic expression of Rrp1b does not alter the growth kinetics of the Mvt-1 cell line.
###end p 112
###begin p 113
(265 KB PDF)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin title 115
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Strain-Specific Variation in Rrp1b Promoter Activity
###end title 115
###begin p 116
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Promoter activity assays reveal that Rrp1b proximal promoter activity was reduced 30% in AKR/J genotype relative to its DBA/2J counterpart (p < 0.001).
###end p 116
###begin p 117
(276 KB PDF)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin title 119
###xml 21 26 <span type="species:ncbi:4932">Yeast</span>
Baits Represented in Yeast-Two Hybrid SIPA1 Interaction Analysis
###end title 119
###begin p 120
(16 KB XLS)
###end p 120
###begin p 121
Click here for additional data file.
###end p 121
###begin title 122
###xml 35 40 <span type="species:ncbi:4932">Yeast</span>
Proteins Interacting With SIPA1 on Yeast-Two Hybrid Interaction Analysis
###end title 122
###begin p 123
(19 KB XLS)
###end p 123
###begin p 124
Click here for additional data file.
###end p 124
###begin title 125
Genes with Expression Associated with Metastasis-Predictive ECM Genes on eQTL Analysis: Chromosome 17 Locus
###end title 125
###begin p 126
(47 KB XLS)
###end p 126
###begin p 127
Click here for additional data file.
###end p 127
###begin title 128
Rrp1b Sequencing Amplicons: Primers and Polymorphisms
###end title 128
###begin p 129
(25 KB XLS)
###end p 129
###begin p 130
Click here for additional data file.
###end p 130
###begin title 131
Promoter Activity Assays for AKR/J and DBA/2J Proximal Rrp1b Promoters
###end title 131
###begin p 132
(30 KB XLS)
###end p 132
###begin p 133
Click here for additional data file.
###end p 133
###begin title 134
###xml 83 87 <span type="species:ncbi:10090">Mice</span>
qPCR Analysis of Rrp1b Expression in the Normal Mammary Tissue of AKR/J and DBA/2J Mice
###end title 134
###begin p 135
(21 KB XLS)
###end p 135
###begin p 136
Click here for additional data file.
###end p 136
###begin title 137
Genes Upregulated by Ectopic Expression of Rrp1b in Mvt-1 Cells
###end title 137
###begin p 138
(142 KB XLS)
###end p 138
###begin p 139
Click here for additional data file.
###end p 139
###begin title 140
Genes Downregulated by Ectopic Expression of Rrp1b in Mvt-1 Cells
###end title 140
###begin p 141
(181 KB XLS)
###end p 141
###begin p 142
Click here for additional data file.
###end p 142
###begin title 143
Hazard Ratio for Genes Associated With Survival
###end title 143
###begin p 144
(17 KB XLS)
###end p 144
###begin p 145
Click here for additional data file.
###end p 145
###begin title 146
Characteristics of the Orange County Breast Cancer Cohort
###end title 146
###begin p 147
(18 KB XLS)
###end p 147
###begin p 148
Click here for additional data file.
###end p 148
###begin title 149
Characteristics of the Greater Baltimore Breast Cancer Cohort
###end title 149
###begin p 150
(18 KB XLS)
###end p 150
###begin p 151
Click here for additional data file.
###end p 151
###begin title 152
Quantitative RT-PCR Primer Sequences
###end title 152
###begin p 153
(19 KB XLS)
###end p 153
###begin p 154
Click here for additional data file.
###end p 154
###begin title 155
Supplementary Data
###end title 155
###begin p 156
A detailed explanation and discussion of the ECM eQTL data.
###end p 156
###begin p 157
(76 KB DOC)
###end p 157
###begin p 158
Click here for additional data file.
###end p 158
###begin title 159
Supplementary Methods
###end title 159
###begin p 160
(62 KB PDF)
###end p 160
###begin p 161
Click here for additional data file.
###end p 161
###begin title 162
Accession Numbers
###end title 162
###begin p 163
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
 Accession numbers for genes mentioned in this paper from the Mammalian Gene Collection () are Rrp1b cDNA BC016569 (MGC:27793, IMAGE ID: 3157173).
###end p 163
###begin p 164
###xml 89 107 89 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-galactosidase</italic>
###xml 118 124 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 134 140 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col3a1</italic>
###xml 149 155 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col6a2</italic>
###xml 165 170 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbln2</italic>
###xml 180 184 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbn1</italic>
###xml 194 199 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mfap5</italic>
###xml 209 213 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppib</italic>
###xml 223 228 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
###xml 238 243 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP1B</italic>
###xml 253 258 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sipa1</italic>
###xml 267 275 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serpinf1</italic>
###xml 289 297 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serping1</italic>
Accession numbers for genes mentioned in this paper from the Entrez Gene database () are beta-galactosidase (957271), Col1a1 (12842), Col3a1 (1281), Col6a2 (12834), Fbln2 (14115), Fbn1 (14118), Mfap5 (50530), Ppib (19035), Rrp1b (72462), RRP1B (23076), Sipa1(20469), Serpinf1 (20317), and Serping1(12258).
###end p 164
###begin p 165
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col3a1</italic>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a1</italic>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a2</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbn1</italic>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbln2</italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mfap5</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp16</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nid1</italic>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serpinf1</italic>
###xml 371 379 371 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Serping1</italic>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Timp2</italic>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnxb</italic>
Accession numbers for probe sets mentioned in this paper from the Affymetrix NetAffx Analysis Center () are Col3a1 (1427884_at), Col1a1 (1423669_at_A, 1455494_at_A), Col1a2 (1423110_at_A, 1446326_at_B, 1450857_a_at_A), Fbn1(1425896_a_at), Fbln2 (1423407_a_at), Mfap5-pending (1418454_at), Mmp2 (1439364_a_at), Mmp16 (1437568_at), Nid1 (1416808_at), Serpinf1(1416168_at), Serping1 (1416625_at), Timp2(1420924_at), and Tnxb (1450798_at).
###end p 165
###begin p 166
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rrp1b</italic>
Accession number for the polymorphism mentioned in this paper from the Entrez SNP database () is Rrp1b (dbSNP ID: rs9306160; 1421G-->A, Pro436Leu)
###end p 166
###begin p 167
XQ and AZ contributed equally to this study.
###end p 167
###begin title 168
Abbreviations
###end title 168
###begin p 169
confidence interval
###end p 169
###begin p 170
extracellular matrix
###end p 170
###begin p 171
Rap exchange factor
###end p 171
###begin p 172
expression quantitative trait locus
###end p 172
###begin p 173
estrogen receptor
###end p 173
###begin p 174
GTPase activating protein
###end p 174
###begin p 175
hazard ratio of death
###end p 175
###begin p 176
linkage disequilibrium
###end p 176
###begin p 177
lymph node
###end p 177
###begin p 178
likelihood ratio statistic
###end p 178
###begin p 179
progesterone receptor
###end p 179
###begin p 180
polyoma middle-T
###end p 180
###begin p 181
quantitative real-time PCR
###end p 181
###begin p 182
recombinant inbred
###end p 182
###begin p 183
reverse-transcription PCR
###end p 183
###begin p 184
single nucleotide polymorphism
###end p 184
###begin p 185
tumor-node-metastasis
###end p 185
###begin title 186
References
###end title 186
###begin article-title 187
Cancer statistics, 2004
###end article-title 187
###begin article-title 188
The curability of breast cancer and the treatment of advanced disease
###end article-title 188
###begin article-title 189
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression
###end article-title 189
###begin article-title 190
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease
###end article-title 190
###begin article-title 191
Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1
###end article-title 191
###begin article-title 192
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17
###end article-title 192
###begin article-title 193
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
###end article-title 193
###begin article-title 194
Polymorphisms of SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer
###end article-title 194
###begin article-title 195
A molecular signature of metastasis in primary solid tumors
###end article-title 195
###begin article-title 196
Gene expression profiling predicts clinical outcome of breast cancer
###end article-title 196
###begin article-title 197
A gene-expression signature as a predictor of survival in breast cancer
###end article-title 197
###begin article-title 198
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis
###end article-title 198
###begin article-title 199
Metastasis predictive signature profiles pre-exist in normal tissues
###end article-title 199
###begin article-title 200
###xml 84 90 <span type="species:ncbi:10090">murine</span>
AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas
###end article-title 200
###begin article-title 201
WebQTL: web-based complex trait analysis
###end article-title 201
###begin article-title 202
Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function
###end article-title 202
###begin article-title 203
An integrative genomics approach to infer causal associations between gene expression and disease
###end article-title 203
###begin article-title 204
###xml 52 56 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice
###end article-title 204
###begin article-title 205
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor
###end article-title 205
###begin article-title 206
###xml 32 37 <span type="species:ncbi:9606">human</span>
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
###end article-title 206
###begin article-title 207
Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'
###end article-title 207
###begin article-title 208
Multiple robust signatures for detecting lymph node metastasis in head and neck cancer
###end article-title 208
###begin article-title 209
###xml 105 113 <span type="species:ncbi:9606">patients</span>
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients
###end article-title 209
###begin article-title 210
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
###end article-title 210
###begin article-title 211
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
###end article-title 211
###begin article-title 212
Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression
###end article-title 212
###begin article-title 213
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product
###end article-title 213
###begin article-title 214
Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion
###end article-title 214
###begin article-title 215
Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis
###end article-title 215
###begin article-title 216
DOCK4, a GTPase activator, is disrupted during tumorigenesis
###end article-title 216
###begin article-title 217
Rap1: a turnabout for the crosstalk between cadherins and integrins
###end article-title 217
###begin article-title 218
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 56 61 <span type="species:ncbi:4932">yeast</span>
The nucleolar antigen Nop52, the human homologue of the yeast ribosomal RNA processing RRP1, is recruited at late stages of nucleologenesis
###end article-title 218
###begin article-title 219
###xml 36 41 <span type="species:ncbi:9606">human</span>
A protein interaction framework for human mRNA degradation
###end article-title 219
###begin article-title 220
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis
###end article-title 220
###begin article-title 221
Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes
###end article-title 221
###begin article-title 222
Set of novel tools for PCR primer design
###end article-title 222
###begin article-title 223
Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers
###end article-title 223
###begin article-title 224
Gene-expression profiles in hereditary breast cancer
###end article-title 224
###begin article-title 225
###xml 52 57 <span type="species:ncbi:9606">human</span>
Systematic variation in gene expression patterns in human cancer cell lines
###end article-title 225
###begin article-title 226
Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer
###end article-title 226
###begin article-title 227
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
###end article-title 227
###begin article-title 228
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 228
###begin p 229
A previous version of this article appeared as an Early Online Release on October 15, 2007 (doi:).
###end p 229
###begin p 230
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. NPSC, SA, DRL, HAC, and KWH conceived and designed the experiments. NPSC, XQ, AGP, BJB, RCW, and LL performed the experiments. NPSC, XQ, AZ, AGP, WHR, JZ, SA, DRL, HAC, and KWH analyzed the data. BJB contributed reagents/materials/analysis tools. NPSC, SA, and KWH wrote the paper.
###end p 230
###begin p 231
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. We would also like to acknowledge support for this research by funding from the NCI (CA58860 and CA 58860-09), the University of California Breast Cancer Research Program (404120), and the Lon Smith Foundation (LVS-35977).
###end p 231
###begin p 232
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 232

